| Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network A Smith, D Howell, R Patmore, A Jack, E Roman British journal of cancer 105 (11), 1684-1692, 2011 | 972 | 2011 |
| Rearrangement of MYC Is Associated With Poor Prognosis in Patients With Diffuse Large B-Cell Lymphoma Treated in the Era of Rituximab S Barrans, S Crouch, A Smith, K Turner, R Owen, R Patmore, E Roman, ... Journal of clinical oncology 28 (20), 3360-3365, 2010 | 755 | 2010 |
| Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes E Bernard, Y Nannya, RP Hasserjian, SM Devlin, H Tuechler, ... Nature medicine 26 (10), 1549-1556, 2020 | 549 | 2020 |
| Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK’s Haematological Malignancy Research Network A Smith, S Crouch, S Lax, J Li, D Painter, D Howell, R Patmore, A Jack, ... British journal of cancer 112 (9), 1575-1584, 2015 | 506 | 2015 |
| Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report SE Lacy, SL Barrans, PA Beer, D Painter, AG Smith, E Roman, SL Cooke, ... Blood, The Journal of the American Society of Hematology 135 (20), 1759-1771, 2020 | 431 | 2020 |
| Epidemiology of lymphomas E Roman, AG Smith Histopathology 58 (1), 4-14, 2011 | 254 | 2011 |
| Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker … A Rosenwald, S Bens, R Advani, S Barrans, C Copie-Bergman, ... Journal of Clinical Oncology 37 (35), 3359-3368, 2019 | 252 | 2019 |
| Time-to-diagnosis and symptoms of myeloma, lymphomas and leukaemias: a report from the Haematological Malignancy Research Network DA Howell, AG Smith, A Jack, R Patmore, U Macleod, E Mironska, ... BMC blood disorders 13, 1-9, 2013 | 165 | 2013 |
| The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research A Smith, E Roman, D Howell, R Jones, R Patmore, A Jack, ... British journal of haematology 148 (5), 739-753, 2010 | 132 | 2010 |
| Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK’s population-based Haematological Malignancy Research Network 2004–15 E Roman, A Smith, S Appleton, S Crouch, R Kelly, S Kinsey, C Cargo, ... Cancer epidemiology 42, 186-198, 2016 | 123 | 2016 |
| Whole genome expression profiling based on paraffin embedded tissue can be used to classify diffuse large B‐cell lymphoma and predict clinical outcome SL Barrans, S Crouch, MA Care, L Worrillow, A Smith, R Patmore, ... British journal of haematology 159 (4), 441-453, 2012 | 112 | 2012 |
| Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hit F Cucco, S Barrans, C Sha, A Clipson, S Crouch, R Dobson, Z Chen, ... Leukemia 34 (5), 1329-1341, 2020 | 108 | 2020 |
| Preferred and actual place of death in haematological malignancy DA Howell, HI Wang, E Roman, AG Smith, R Patmore, MJ Johnson, ... BMJ supportive & palliative care 7 (2), 150-157, 2017 | 91 | 2017 |
| The incidence and prevalence of paroxysmal nocturnal hemoglobinuria (PNH) and survival of patients in Yorkshire. A Hill, PJ Platts, A Smith, SJ Richards, MJ Cullen, QA Hill, E Roman, ... Blood, The Journal of the American Society of Hematology 108 (11), 985-985, 2006 | 91 | 2006 |
| Determinants of survival in patients with chronic myeloid leukaemia treated in the new era of oral therapy: findings from a UK population-based patient cohort AG Smith, D Painter, DA Howell, P Evans, G Smith, R Patmore, A Jack, ... BMJ open 4 (1), e004266, 2014 | 88 | 2014 |
| Childhood leukaemia and socioeconomic status: fact or artefact? A report from the United Kingdom childhood cancer study (UKCCS) A Smith, E Roman, J Simpson, P Ansell, NT Fear, T Eden International journal of epidemiology 35 (6), 1504-1513, 2006 | 77 | 2006 |
| Estimating the prevalence of hematological malignancies and precursor conditions using data from Haematological Malignancy Research Network (HMRN) J Li, A Smith, S Crouch, S Oliver, E Roman Cancer causes & control 27, 1019-1026, 2016 | 75 | 2016 |
| Cohort profile: the Haematological Malignancy Research Network (HMRN): a UK population-based patient cohort A Smith, D Howell, S Crouch, D Painter, J Blase, HI Wang, A Hewison, ... International Journal of Epidemiology 47 (3), 700-700g, 2018 | 74 | 2018 |
| Palliative care specialists’ perceptions concerning referral of haematology patients to their services: findings from a qualitative study D McCaughan, E Roman, AG Smith, AC Garry, MJ Johnson, RD Patmore, ... BMC Palliative Care 17, 1-11, 2018 | 68 | 2018 |
| The use of targeted sequencing and flow cytometry to identify patients with a clinically significant monocytosis C Cargo, M Cullen, J Taylor, M Short, P Glover, S Van Hoppe, A Smith, ... Blood, The Journal of the American Society of Hematology 133 (12), 1325-1334, 2019 | 66 | 2019 |
